George Soros acquired 140 Thousand Immunovant shares worth $4.03 Million. That's 0.15% of their equity portfolio (78th largest holding). The investor's estimated purchase price is $4.09 Million, resulting in a loss of 1.4%.
Avg closing price
Price range
Increased shares by 86.7% (+65 Thousand shares)
Q4 2023